First trimester Down syndrome screening is less effective and the number of invasive procedures is increased in women younger than 35 years of age

, , &
Journal of Evaluation in Clinical Practice 19 (2):324-326 (2013)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1111/j.1365-2753.2012.01826.x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,410

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

First‐trimester Down syndrome screening in women younger than 35 years old and cost‐effectiveness analysis in Taiwan population.Ching-Yu Chou, Fon-Jou Hsieh, Mei-Leng Cheong, Fa-Kung Lee, Bo-Quing She & Ming-Song Tsai - 2009 - Journal of Evaluation in Clinical Practice 15 (5):789-796.
First trimester prenatal diagnosis: earlier is not necessarily better.J. A. Boss - 1994 - Journal of Medical Ethics 20 (3):146-151.
Can safety assurance procedures in the food industry be used to evaluate a medical screening programme? The application of the Hazard Analysis and Critical Control Point system to an antenatal serum screening programme for Down's syndrome. Stage 2: overcoming the hazards in programme delivery.M. Clare Derrington, Elizabeth S. Draper, Ronald T. Hsu & Jennifer J. Kurinczuk - 2003 - Journal of Evaluation in Clinical Practice 9 (1):49-57.
Can safety assurance procedures in the food industry be used to evaluate a medical screening programme? The application of the Hazard Analysis and Critical Control Point system to an antenatal serum screening programme for Down's syndrome. Stage 1: identifying significant hazards.M. Clare Derrington, Janet D. Glencross, Elizabeth S. Draper, Ronald T. Hsu & Jennifer J. Kurinczuk - 2003 - Journal of Evaluation in Clinical Practice 9 (1):39-47.
Challenging the rhetoric of choice in prenatal screening.Victoria Seavilleklein - 2008 - Bioethics 23 (1):68-77.
Cost-effectiveness analysis of triple test in second-trimester maternal serum screening for Down’s syndrome: an experience from Taiwan with decreasing birth rate but increasing population of old pregnant women.Hsiao-Lin Hwa, Ming-Fang Yen, Chen-Li Lin, Tsang-Ming Ko, Fon-Jou Hsieh & Tony Hsiu-Hsi Chen - 2008 - Journal of Evaluation in Clinical Practice 14 (2):191-197.
Prenatal screening in Jewish law.J. Brown - 1990 - Journal of Medical Ethics 16 (2):75-80.
A new era in prenatal testing: are we prepared? [REVIEW]Dagmar Schmitz - 2013 - Medicine, Health Care and Philosophy 16 (3):357-364.
Maternal serum testing: Is invasive testing a passing era.Marcia Riordan - 2012 - Bioethics Research Notes 24 (1):7.
The ethics of screening: is 'screeningitis' an incurable disease?D. Shickle & R. Chadwick - 1994 - Journal of Medical Ethics 20 (1):12-18.
Genetic screening and ethics: European perspectives.Ruth Chadwick, Henk ten Have, Jfrgen Husted, Mairi Levitt, Tony McGleenan, Darren Shickle & Urban Wiesing - 1998 - Journal of Medicine and Philosophy 23 (3):255 – 273.
Bioethical concepts in theory and practice: an exploratory study of prenatal screening in Iceland. [REVIEW]Helga Gottfreðsdóttir & Vilhjálmur Árnason - 2011 - Medicine, Health Care and Philosophy 14 (1):53-61.
Antenatal screening and its possible meaning from unborn baby's perspective.Sahin Aksoy - 2001 - BMC Medical Ethics 2 (1):1-11.

Analytics

Added to PP
2013-11-24

Downloads
28 (#574,026)

6 months
4 (#799,368)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Add more references